Healthcare & Biotech

Why Gilead Sciences Inc (NASDAQ:GILD) Stock Owners Shouldn’t Expect Acquisitions

Gilead Sciences Inc does not need to acquire for GILD stock to reverse course and trade higher. Brian & Liam take two angles on Gilead stock.

Also posted in Biotech Hunter, Members | | Tagged , | Leave a comment

Is Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Stock A Buy After OCA Update?

ICPT jumped 6% after Intercept Pharmaceuticals issued an update on OCA in treating NASH. Is Intercept stock now a buy?

Also posted in Biotech Hunter | | Tagged , | Leave a comment

1 Bullish Takeaway From Gilead Sciences (NASDAQ:GILD) Stock After Earnings

Gilead Sciences’ guidance was horrible, & GILD stock should be down 15%. There’s a good reason it only fell 5%, and why Gilead stock will recover.

Also posted in Members, Timely Analysis | | Tagged , | Leave a comment

ACADIA Pharmaceuticals (ACAD) Buyout: Why The AstraZeneca (AZN) Rumor Matters

A bidding war for Acadia Pharmaceuticals and Nuplazid is likely to ensue after buyout rumors last Friday. Great news for ACAD stock owners.

Also posted in Editor's Pick, Members, Mergers & Acquisitions | | Tagged , , , , , | Leave a comment

Cara Therapeutics Inc (NASDAQ:CARA) Stock: Buy, Sell, or Hold After Massive Return?

BNL analyst Eddy Parton called CARA stock back in November before a 60% gain. Eddy revisits Cara Therapeutics to determine whether to buy, sell, or hold.

Also posted in Editor's Pick, Members | | Tagged , | 2 Comments

Is Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Stock A Buy After 15% Loss?

SGYP stock fell nearly 15% after Synergy Pharmaceuticals announced a larger offering at a lower price than expected. However, that’s not the biggest concern

Also posted in Members, Timely Analysis | | Tagged , , , , | Leave a comment

Walgreens Rite Aid Buyout: Investors Must Read Between The Lines! (RAD) (WBA)

The Walgreens Rite Aid buyout terms have changed, and RAD stock owners must consider there is more to this story with WBA.

Also posted in Editor's Pick, Members, Mergers & Acquisitions, Timely Analysis | | Tagged , , , , | 2 Comments